Skip to main content
Malagola Michele on Muck Rack

Malagola Michele

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Malagola

Contact Malagola, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Outcome of Patients With Acute Myeloid Leukemias or Myelodysplastic Syndromes After Relapsing From Allogeneic Stem Cell Transplantation: The GITMO AML/MDS‐Relapse Registry Study

|
By BMT Unit, Malagola Michele, Castagna Luca, Matranga Domenica
| Wiley Online Library Verified
To the Editor, Disease relapse represents the main cause of treatment failure after allogeneic stem cell transplantation (Allo-SCT) in Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS) patients [1]. Thus, minimal residual disease (MRD) monitoring following allo-SCT is a mainstay of good clinical practice.
Open in Who Shared Issue with article?
See all 1 articles